Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the special report in accordance with article 7:228 of the Belgian Code of Companies and Associations, regarding the continuation of the business activities CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Approval of the continuation of the business activities CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the annual report of the Board of Directors regarding the fiscal year ended on 31 December 2024 CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the report of the statutory auditor AUDIT-RELATED ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Approval of the annual accounts for the fiscal year ended on 31 December 2024 CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Allocation of the results CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Release of liability to the directors and the statutory auditor for the exercise of their mandate during the past fiscal year AUDIT-RELATED ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the special report in accordance with article 7:228 of the Belgian Code of Companies and Associations, regarding the continuation of the business activities CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Approval of the continuation of the business activities CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the annual report of the Board of Directors regarding the fiscal year ended on 31 December 2024 CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Acknowledgment of the report of the statutory auditor AUDIT-RELATED ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Approval of the annual accounts for the fiscal year ended on 31 December 2024 CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Allocation of the results CORPORATE GOVERNANCE ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR Flamingo Therapeutics, Inc. 07/07/2025 Release of liability to the directors and the statutory auditor for the exercise of their mandate during the past fiscal year AUDIT-RELATED ISSUER 243458.000000 0.000000 FOR 243458.000000 FOR ProThera Limited 10/21/2025 To receivee and consider the Company's Financial Statements for the year ended 31 December 2023 and the reports of the Directors and Auditors on those Financial Statements AUDIT-RELATED ISSUER 346666.000000 0.000000 FOR 346666.000000 FOR ProThera Limited 10/21/2025 To review the Company's affairs CORPORATE GOVERNANCE ISSUER 346666.000000 0.000000 FOR 346666.000000 FOR ProThera Limited 10/21/2025 To re-appoint the Company statutory auditors to continue in office pursuant to section 383 of the Companies Act 2014 AUDIT-RELATED ISSUER 346666.000000 0.000000 FOR 346666.000000 FOR ProThera Limited 10/21/2025 To authorise the directors to approve the remuneration of the statutory auditors for the year ended 31 December 2024 AUDIT-RELATED ISSUER 346666.000000 0.000000 FOR 346666.000000 FOR ProThera Limited 10/21/2025 To adopt the Constitution of the Company in the form presented CORPORATE GOVERNANCE ISSUER 346666.000000 0.000000 FOR 346666.000000 FOR